Related Experiment Video
Updated: Jul 29, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate
S D Lawn1, V Yardley, F Vega-Lopez
1Hospital for Tropical Diseases, Mortimer Market Centre, Capper Street, London WC1E 6AU, UK. stevelawn@yahoo.co.uk
Abstract:
Treatment outcome was determined among a cohort of travellers who returned to the UK between February 2000 and February 2001 with New World cutaneous leishmaniasis caused by species of the Leishmania (Viannia) subgenus. Among 18 patients who completed treatment with 20 mg/kg/d of i.v. sodium stibogluconate (NaSb) for 20 d, early relapse of disease occurred in 2 patients with regional dissemination in 1 and mucocutaneous involvement in the other. Drug susceptibility testing in vitro of the clinical isolate from 1 of these patients confirmed tolerance to high concentrations of NaSb.
Related Concept Videos
Fungal Phylum Microsporidia
Rocky Mountain Spotted Fever
Leishmaniasis
American Trypanosomiasis
Antiprotozoal Agents

